Pre-earnings options volume in CTI BioPharma is 1.7x normal with calls leading puts 16:1. Implied volatility suggests the market is anticipating a move near 9.1%, or 46c, after results are released. Median move over the past eight quarters is 8.5%.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CTIC:
- CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results
- CTI BioPharma reports Q4 EPS (14c), consensus (10c)
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue